These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24445620)

  • 21. Outcomes of residential treatment of substance abuse in hospital- and community-based programs.
    Moos RH; King MJ; Patterson MA
    Psychiatr Serv; 1996 Jan; 47(1):68-74. PubMed ID: 8925349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of treatments for people with severe mental illnesses and co-occurring substance use disorders.
    Drake RE; Mueser KT; Brunette MF; McHugo GJ
    Psychiatr Rehabil J; 2004; 27(4):360-74. PubMed ID: 15222148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individual-, family-, and school-level interventions targeting multiple risk behaviours in young people.
    MacArthur G; Caldwell DM; Redmore J; Watkins SH; Kipping R; White J; Chittleborough C; Langford R; Er V; Lingam R; Pasch K; Gunnell D; Hickman M; Campbell R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009927. PubMed ID: 30288738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Permanent supportive housing: assessing the evidence.
    Rog DJ; Marshall T; Dougherty RH; George P; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Mar; 65(3):287-94. PubMed ID: 24343350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient and program predictors of 12-month outcomes for homeless veterans following discharge from time-limited residential treatment.
    McGuire J; Rosenheck RA; Kasprow WJ
    Adm Policy Ment Health; 2011 May; 38(3):142-54. PubMed ID: 20814735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Consumer and family psychoeducation: assessing the evidence.
    Lyman DR; Braude L; George P; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Apr; 65(4):416-28. PubMed ID: 24445678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Dual Diagnosis Capability of Residential Addiction Treatment centres: priorities and confidence to improve capability following a review process.
    Matthews H; Kelly PJ; Deane FP
    Drug Alcohol Rev; 2011 Mar; 30(2):195-9. PubMed ID: 21355921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using NIATx strategies to implement integrated services in routine care: a study protocol.
    Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP
    BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of interventions to reduce homelessness: a systematic review and meta-analysis.
    Munthe-Kaas HM; Berg RC; Blaasvær N
    Campbell Syst Rev; 2018; 14(1):1-281. PubMed ID: 37131370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders.
    Grella CE; Gil-Rivas V; Cooper L
    J Behav Health Serv Res; 2004; 31(1):38-49. PubMed ID: 14722479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of program services on treatment outcomes of patients with comorbid mental and substance use disorders.
    Grella CE; Stein JA
    Psychiatr Serv; 2006 Jul; 57(7):1007-15. PubMed ID: 16816286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.
    Kelly TM; Daley DC; Douaihy AB
    J Dual Diagn; 2014; 10(3):108-17. PubMed ID: 25392284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient vs. inpatient treatment for the chronically mentally ill with substance use disorders.
    Kofoed L
    J Addict Dis; 1993; 12(3):123-37. PubMed ID: 8251539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of VA mental health services by older patients with substance use disorders.
    Brennan PL; Nichols KA; Moos RH
    Psychiatr Serv; 2002 Jul; 53(7):836-41. PubMed ID: 12096166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive validity of a quality measure for intensive substance use disorder treatment.
    Schmidt EM; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Finney JW; Asch SM; Humphreys K; Trafton J; Vanneman M; Harris AHS
    Subst Abus; 2017; 38(3):317-323. PubMed ID: 27435754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensive Outpatient Treatment (IOP) of Behavioral Health (BH) Problems: Engagement Factors Predicting Subsequent Service Utilization.
    Costa M; Plant RW; Feyerharm R; Ringer L; Florence AC; Davidson L
    Psychiatr Q; 2020 Jun; 91(2):533-545. PubMed ID: 32043237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.